FELIMAZOLE 5MG DIN 02332663
Health Canada record
| Active ingredient(s) | METHIMAZOLE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 12-Jan-2010 |
| Current status date | 12-Jan-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Dechra Veterinary Products Inc. — licence 102149, currently licensed, last inspection rating C (2025-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHIMAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02411512 | FELIMAZOLE 1.25 MG | DECHRA LTD | Tablet | METHIMAZOLE 1.25 MG | Marketed |
| 02332655 | FELIMAZOLE 2.5MG | DECHRA LTD | Tablet | METHIMAZOLE 2.5 MG | Marketed |
| 02490633 | JAMP METHIMAZOLE | JAMP PHARMA CORPORATION | Tablet | METHIMAZOLE 10 MG | Marketed |
| 02490625 | JAMP METHIMAZOLE | JAMP PHARMA CORPORATION | Tablet | METHIMAZOLE 5 MG | Marketed |
| 02480115 | MAR-METHIMAZOLE | MARCAN PHARMACEUTICALS INC | Tablet | METHIMAZOLE 10 MG | Marketed |
| 02480107 | MAR-METHIMAZOLE | MARCAN PHARMACEUTICALS INC | Tablet | METHIMAZOLE 5 MG | Marketed |
| 02258935 | APO-METHIMAZOLE | APOTEX INC | Tablet | METHIMAZOLE 5 MG | Dormant |
| 02265869 | DOM-METHIMAZOLE | DOMINION PHARMACAL | Tablet | METHIMAZOLE 5 MG | Cancelled Pre Market |
| 02489716 | METHIMAZOLE TABLETS USP | ENDO OPERATIONS LTD. | Tablet | METHIMAZOLE 5 MG | Cancelled Pre Market |
| 02489732 | METHIMAZOLE TABLETS USP | ENDO OPERATIONS LTD. | Tablet | METHIMAZOLE 20 MG | Cancelled Pre Market |
| 02489724 | METHIMAZOLE TABLETS USP | ENDO OPERATIONS LTD. | Tablet | METHIMAZOLE 10 MG | Cancelled Pre Market |
| 02265850 | PHL-METHIMAZOLE | PHARMEL INC | Tablet | METHIMAZOLE 5 MG | Cancelled Pre Market |
| 02244323 | PMS-METHIMAZOLE | PHARMASCIENCE INC | Tablet | METHIMAZOLE 5 MG | Cancelled Post Market |
| 02296039 | TAPAZOLE | KNIGHT THERAPEUTICS INC. | Tablet | METHIMAZOLE 10 MG | Cancelled Post Market |
| 02296047 | TAPAZOLE | PALADIN PHARMA INC. | Tablet | METHIMAZOLE 20 MG | Cancelled Pre Market |
| 00015741 | TAPAZOLE | KNIGHT THERAPEUTICS INC. | Tablet | METHIMAZOLE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37681 | 2026-06-10 | Supplement to a New Drug Submission (SNDS) | Drug product formulation change involving overage of active ingredient to compensate for any loss during the manufacturing process, and changes to the finished product manufacturing process |
| 10543 | 2009-08-25 | New Drug Submission (NDS) |
International API supply for METHIMAZOLE
6 active FDA Drug Master Files.
Request a quote for FELIMAZOLE 5MG